Press Releases

CD Formulation Launches Tailored Solutions for Increased Bioavailability Excipients

Alfa Chemistry Launches a Chemistry-Focused Technology Platform: Advanced and Flexible

CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities

CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities Company wins prestigious accolade for contribution to Pfizer/BioNTech BNT162b2 COVID-19 vaccine development King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has won the Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities.

BioIVT Appoints Jennifer Murphy as Senior Vice President of Global Commercial Operations

Jennifer has more than 16 years’ commercial leadership experience in the diagnostics and life sciences industries.

Ripple Science and Curavit Clinical Research Sign Partnership Agreement to Accelerate Decentralized Clinical Trials (DCTs)

Ripple Enterprise software to be deployed as part of the digital transformation in clinical trials spearheaded by Curavit.

DFE Pharma, Harro Höfliger, and Sterling partner in “INTO” to provide formulation services for respiratory products

DFE Pharma, Harro Höfliger, and Sterling partner in “INTO” to provide formulation services for respiratory products Inhalation Together (INTO) helps pharmaceutical companies in the respiratory field to simplify formulation development New York, USA (24th March 2022) – Three leading companies in their respective fields - DFE Pharma (excipients solution provider), Harro Höfliger (equipment supplier), and Sterling (API manufacturer) - announced a unique partnership with the establishment of “Inhalation Together” (INTO) in the field of dry powder inhalation (DPI).

BOC Sciences Optimizes PROTAC Platform to Boost Related Research

BOC Sciences optimizes its PROTAC platform of protein degradation technology to boost PROTAC research and development.

Creative Bioarray Develops Cell Immortalization Kits and Immortalized Human Cells to Support Immortalized Cell Research

ActiGraph Joins Decentralized Trials & Research Alliance

ActiGraph further solidifies its reputation as an innovator in clinical trials by joining an organization aimed to make research participation accessible to all.

CD Formulation Announces to Offer Nitrosamine Impurities Analysis Service for Drug Formulation Projects

Earlier this month, CD Formulation announces that it is now capable of providing nitrosamine impurities analysis service for customers who are involved with drug formulation projects and need help from CRO companies like CD Formulation.

Tower Cold Chain launches KTEvolution container for pharmaceutical transport

Stanley Capital-backed portfolio company DSS acquires MyMeds&Me

Stanley Capital-backed portfolio company DSS acquires MyMeds&Me 04 April 2022, London - Stanley Capital Partners LLP (SCP), the European and US-focused mid-market private equity firm, today announced the acquisition of MyMeds&Me Limited (MMM) by its portfolio company Drug Safety and Pharmacovigilance Services Solutions (DSS). DSS is a leading global provider of pharmacovigilance services under the brand Bioclinica. The financial terms of the transaction are not being disclosed.

BioIVT Acquires Commercial Blood Bank Tennessee Blood Services

This transaction expands BioIVT’s donor network and increases its capacity to provide fresh whole blood, plasma, serum, and red blood cells for drug and diagnostic development.

CPHI North America opens as 65% of US companies forecast growth in excess of 20% in 2022

Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

CluePoints Continues Impressive Global Growth with Three New Senior Appointments

CluePoints Continues Impressive Global Growth with Three New Senior Appointments The company welcomes new VP Marketing, VP People, and VP Business Operations to its expanding team King of Prussia, PA – 5th April, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust is the new VP Business Operations.

ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announces significant growth in the global footprint of its LifeSphere Clinical software, following the customer wins of two prominent institutions in the Asia Pacific and Middle East regions.

Celerion Announces Investment in ADME Suite of Services

Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, has announced that it has made a significant investment in its ADME (Absorption, Distribution, Metabolism and Excretion) suite of services to meet continuously increasing demand to conduct these studies. This investment includes expanding laboratory space, adding new capabilities as well as a dedicated customer service team.

Rho Hires Global VP of Quality Assurance to Support International Expansion following Acquisition

Swiss CDMO expands capsule filling capabilities